5TRU
Structure of the first-in-class checkpoint inhibitor Ipilimumab bound to human CTLA-4
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | APS BEAMLINE 24-ID-E |
| Synchrotron site | APS |
| Beamline | 24-ID-E |
| Temperature [K] | 100 |
| Detector technology | CCD |
| Collection date | 2009-08-02 |
| Detector | ADSC QUANTUM 315 |
| Wavelength(s) | 0.979 |
| Spacegroup name | C 2 2 21 |
| Unit cell lengths | 95.844, 197.502, 148.117 |
| Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
| Resolution | 34.910 - 3.000 |
| R-factor | 0.2067 |
| Rwork | 0.203 |
| R-free | 0.26770 |
| Structure solution method | MOLECULAR REPLACEMENT |
| Starting model (for MR) | 1i85 |
| RMSD bond length | 0.009 |
| RMSD bond angle | 1.461 |
| Data reduction software | HKL-2000 |
| Data scaling software | SCALEPACK |
| Phasing software | MOLREP |
| Refinement software | REFMAC (5) |
Data quality characteristics
| Overall | Inner shell | Outer shell | |
| Low resolution limit [Å] | 34.910 | 50.000 | 3.050 |
| High resolution limit [Å] | 3.000 | 8.130 | 3.000 |
| Rmerge | 0.143 | 0.058 | 0.820 |
| Total number of observations | 181876 | ||
| Number of reflections | 28514 | ||
| <I/σ(I)> | 6.1 | ||
| Completeness [%] | 99.7 | 97.6 | 99.9 |
| Redundancy | 6.4 | 5.7 | 6.6 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | VAPOR DIFFUSION | 7.5 | 291 | 0.1M ammonium sulfate, 0.1M Tris pH 7.5, 20% PEG 1500 |






